EWTX Operating Cash Flow (Statement)
Edgewise Therapeutics Inc · Operating Cash Flow (Statement)
EWTX Operating Cash Flow (Statement)
Latest reported-$159.42Mperiod ending
EWTX Cash from Operations (-$9.17M → -$159.42M)
Annual operating cash flow (statement)
High-resolution chart · PNG
EWTX operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -143,816,000 | |
| -109,028,000 | |
| -91,948,000 | |
| -52,635,000 | |
| -33,507,000 | |
| -14,634,000 | |
| -9,171,000 |